Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 9/20 | 0.32 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.31 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.30 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.30 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2616357 | 0.82 | CES1 (0.39) | CES1CES2LPAR1LPAR3 | |
| SCHEMBL13325151 | 0.82 | FDPS (0.30) | FDPS | |
| SCHEMBL2345427 | 0.80 | CES2 (0.45) | FDPSCES1CES2LPAR1LPAR3 | |
| SCHEMBL5844557 | 0.79 | — | — | |
| SCHEMBL13849607 | 0.78 | CES2 (0.48) | FDPSCES1CES2LPAR1LPAR3 | |
| SCHEMBL11603249 | 0.78 | CES2 (0.48) | FDPSCES1CES2LPAR1LPAR3 | |
| SCHEMBL867879 | 0.73 | — | — | |
| SCHEMBL85653 | 0.73 | NR1H2 (0.36) | CES1NR1H2NR1H3ALDH1A1 | |
| SCHEMBL9314294 | 0.73 | — | — | |
| SCHEMBL11990036 | 0.73 | ALDH1A1 (0.35) | FDPSCES1NR1H2NR1H3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110903589-B | High-voltage soft polyolefin wire material for new energy automobile and preparation method thereof | Suzhou Baima New Material Co.,Ltd. (CN) | 2021-08-31 | — | — | CN | claimed |
| WO-2021076131-A1 | PHOTOSENSITIVE COMPOSITIONS AND APPLICATIONS THEREOF | PROMERUS, LLC (US) | 2021-04-22 | — | — | WO | claimed |
| CN-110903589-A | High-voltage soft polyolefin wire material for new energy automobile and preparation method thereof | 苏州铂玛新材料有限公司 | 2020-03-24 | — | — | CN | claimed |
| US-11785845-B2 | Composition | FUJIFILM CORPORATION (JP) | 2023-10-10 | — | — | US | disclosed |
| EP-3743430-B1 | AMINOPYRROLOTRIAZINES AS KINASE INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2023-08-02 | — | — | EP | disclosed |
| US-11548859-B2 | Method for producing (5,S)-4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4Hisoxazol-3-yl]-2-methyl-benzoic acid | INTERVET INC. (US) | 2023-01-10 | — | — | US | disclosed |
| WO-2022124182-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING POLYMER AND COMPOSITION | セントラル硝子株式会社 | 2022-06-16 | — | — | WO | disclosed |
| WO-2022124183-A1 | FLUORINE-CONTAINING POLYMER | セントラル硝子株式会社 | 2022-06-16 | — | — | WO | disclosed |
| US-20220073479-A1 | Method for Producing (5,S)-4-[5-(3,5-Dichlorophenyl)-5-(Trifluoromethyl)-4Hisoxazol-3-YL]-2-Methyl-Benzoic Acid | INTERVET INC. (US) | 2022-03-10 | — | — | US | disclosed |
| US-20220045283-A1 | COMPOSITION | FUJIFILM CORPORATION (JP) | 2022-02-10 | — | — | US | disclosed |
| CN-110903589-B | High-voltage soft polyolefin wire material for new energy automobile and preparation method thereof | Suzhou Baima New Material Co.,Ltd. (CN) | 2021-08-31 | — | — | CN | disclosed |
| US-7306853-B2 | Ultra-large scale integrated interconnect structures; forming via and/or line patterns in a curable caged polysilsesquioxane, curing and filling the patterns with a conductor; combines the functions of a photoresist and a conventional low-k dielectric into a single material | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2007-12-11 | — | — | US | disclosed |
| US-20070231734-A1 | Polymer, a photoacid generator and a dissolution modification agent; patterning; image resolution | GLOBALFOUNDRIES U.S. INC. | 2007-10-04 | — | — | US | disclosed |
| US-20070178405-A1 | Positive resist composition and method of pattern formation with the same | FUJI PHOTO FILM CO., LTD. | 2007-08-02 | — | — | US | disclosed |
| WO-2007062314-A2 | HETEROCYCLIC CETP INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-05-31 | — | — | WO | disclosed |
| WO-2007062308-A2 | HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-05-31 | — | — | WO | disclosed |
| EP-1757990-A1 | RESIN COMPOSITION FOR FORMING FINE PATTERN AND METHOD FOR FORMING FINE PATTERN | JSR Corporation (JP) | 2007-02-28 | — | — | EP | disclosed |
| US-20050089800-A1 | Photoresist polymer and photoresist composition containing the same | HYNIX SEMICONDUCTOR INC. (KR) | 2005-04-28 | — | — | US | disclosed |
| US-5254755-A | Solvents, cleaning compounds | ALLIED-SIGNAL INC. (US) | 1993-10-19 | — | — | US | disclosed |
| WO-1992010454-A1 | PARTIALLY FLUORINATED ALKANOLS HAVING A TERTIARY STRUCTURE | ALLIED-SIGNAL INC. (US) | 1992-06-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220045283-A1 | COMPOSITION | ADH1A, ADH1C, SLC19A2 | FDPS 1427/4885CES1 224/4885NR1H2 794/4885 |
| US-11785845-B2 | Composition | ADH1A, ADH1C, SLC19A2 | FDPS 1427/4885CES1 224/4885NR1H2 794/4885 |
| US-20220073479-A1 | Method for Producing (5,S)-4-[5-(3,5-Dichlorophenyl)-5-(Trifluoromethyl)-4Hisoxazol-3-YL]-2-Methyl-Benzoic Acid | KDM5A, GABRA5, KDM5B | FDPS 282/4885CES1 2357/4885NR1H2 3793/4885 |
| US-11548859-B2 | Method for producing (5,S)-4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4Hisoxazol-3-yl]-2-methyl-benzoic acid | GABRA5, KDM5A, KDM5B | FDPS 274/4885CES1 1989/4885NR1H2 3764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.